California Texas Louisiana New York Iowa Oregon Nebraska Missouri Washington Ohio Colorado Tennessee Pennsylvania Florida Alabama North Carolina South Carolina Arkansas Kentucky Oklahoma Michigan Indiana Illinois Virginia Massachusetts Maryland Nevada Minnesota Arizona Alaska New Mexico Mississippi Wisconsin Kansas Georgia Maine Montana West Virginia Vermont North Dakota Utah Wyoming South Dakota Idaho RH

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2568 blog entries.

Alabama

The Department of Insurance (DOI) PBM Compliance Division has taken its first action against non-compliant PBMs. Actions have been filed against two entities: one taken in October against Drexi, Inc. for operating without a PBM license in the state, and one taken against Express Scripts, Inc. (ESI) this week for several violations, including charging of illegal fees; under payment of reimbursements; and failure and refusal to provide accounts, documents, records, files, information and matters relevant to the substance of complaints. The Department is enforcing Act 2025-36, also known as the Community Pharmacy Relief Act. Stay informed by visiting the DOI PBM Compliance Division page and the PBM Actions page.  

Also in Alabama, the Board of Pharmacy proposed these rules for adoption. The required public comment period is now open, and we encourage all members to review them.  

File written comments directly with the Board of Pharmacy as directed in the cover sheet for the rule. Deadlines for comments are provided on the rule filings. All written comments should be sent to Wpassmore@albop.com by the deadlines noted.  

Finally in Alabama, the Board of Pharmacy scheduled several upcoming meetings for 2026, including April 15, May 20, June 17, July 15, August 19, September 16, October 14, November 18 and December 16. All meetings begin at 9:00 am CST/CDT unless otherwise noted.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-03-27T09:40:16-04:00March 27, 2026|Alabama|

California

Due to an overwhelming response, the Board of Pharmacy is opening more spots for those interested in attending a listening session on pharmacists provided consultation. Seeking to minimize barriers that exist for pharmacists providing consultation to patients, the Board is interested in hearing from licensed California pharmacists to gather information to assist in evaluating the Board's current consultation requirements. In addition, separate listening sessions will be scheduled so the Board can obtain input from patients and public participants.  

Sessions will be conducted over WebEx. Please see the schedule of dates and times below. The Board respectfully requests individuals to register for ONLY ONE session to ensure other pharmacists have the same opportunity. If you previously registered for a session, please do not register for an additional session date.  

We have increased the meeting capacity; however, space is still limited, and registration is required. To register, click on the link below for your preferred session:  

Questions to be discussed during the listening session include:  

  1. Do you believe patient consultation is needed for all prescriptions? 
  2. How and where does the pharmacist provide patient consultation? 
  3. Does the patient receive the medication prior to consultation? 
  4. Should the pharmacy be required to document the consultation? 
  5. Can technology assist in identifying, documenting, and providing patient consultation? 
  6. What challenges or barriers exist making it difficult for the pharmacist to provide consultation? 
  7. What is your vision of best practice for patient consultation? 
  8. Are there opportunities for compensation for medication reviews and patient counseling? 
  9. If you mail or deliver prescriptions to patients, how do you provide consultation?Do you believe the requirements should be different than face-to-face consultation?  

The information provided will be considered during an upcoming Enforcement and Compounding Committee meeting.  

Also in California, the Board of Pharmacy published its 2026 Lawbook.   

Finally in California, NOTICE IS HEREBY GIVEN that the Board of Pharmacy (Board) has proposed modifications to the proposed regulatory text in section 1717.11 of article 2, division 17, title 16 of the California Code of Regulations, related to REMOTE PROCESSING. These regulations were originally noticed on January 9 and approved as modified by the Board at its March 18 meeting. Materials regarding this proposal can be found online or by requesting them from the contact person identified below.  

Any person who wishes to comment on the proposed modifications may do so by submitting written comments between March 19 and April 3 to the following:  

Contact Name: Debbie Damoth  

Address: 2720 Gateway Oaks Drive, Suite 100 Sacramento, CA 95833  

Fax number: (916) 574-8618  

Email Address: PharmacyRulemaking@dca.ca.gov  

Please note comments should be restricted to the most recent modifications made to the proposed regulations. The Board is not required to respond to comments on other aspects of the proposed regulations received in response to this notice.  

Any comments previously submitted remain in the rulemaking file and will be responded to by the Board's staff as part of the Final Statement of Reasons. All written comments received by April 3 that pertain to these modifications, will be reviewed and responded to by the Board's staff as part of the compilation of the rulemaking file.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-03-27T09:39:40-04:00March 27, 2026|California|

Colorado

SB26-032, a bill designed to expand access to pharmacy vaccine services by increasing pharmacists' authority to prescribe and administer vaccines and by providing liability protections for pharmacists, passed both legislative chambers and was sent to Gov. Jared Polis (D) to sign into law. 

Also in Colorado, after months of stakeholder negotiations, HB 26-1336, the Increase Access to Pharmacy Services bill that NACDS supports, was filed last week. The bill would strengthen coverage requirements for the clinical services pharmacists provide within their scope of practice and expand pharmacy technicians' technical and nondiscretionary tasks that do not require a pharmacist's expertise and professional judgement. The bill also includes provisions that expand pharmacists' scope of practice to provide test & treat services for families with children 12 years of age and younger. A hearing is scheduled in the House Health Care and Health Insurance Committee on March 31. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-03-27T09:38:54-04:00March 27, 2026|Colorado|

Georgia

The Board of Pharmacy published a Notice of Intent to Adopt, Amend, or Repeal Rule 480-10A-.08 Notification to Patients, and Notice of Public Hearing on March 3. The Board also issued a Notice to Treatment Providers regarding Board Policy #9 on February 26.  

Additionally, the Board posted a consumer alert about reports of scammers impersonating Board and Georgia Drugs and Narcotics Agency (GDNA) staff on March 4.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-03-27T09:38:21-04:00March 27, 2026|Georgia|

Illinois

The Department of Financial and Professional Regulation released the Compliance Capsule Spring 2026 newsletter, providing regulatory updates and compliance information for licensed professionals, including pharmacists.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-03-27T09:37:50-04:00March 27, 2026|Illinois|

Kansas

The Consumer Prescription Protection and Accountability Act, supported by NACDS and the Kansas Pharmacy Association, has been approved by both legislative chambers and was sent to Gov. Laura Kelly (D) for signature. SB 360 is a comprehensive PBM reform bill that clarifies auditing procedures, specifies reporting requirements and strengthens enforcement authority by enabling both compliance and financial examinations. 

Also in Kansas, the Board of Pharmacy issued the March 2026 newsletter. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-03-27T09:37:18-04:00March 27, 2026|Kansas|

Maryland

The Prescription Drug Affordability Board (PDAB) invites you to attend the April Board Meeting scheduled for April 13 at 9:00 am. Part of the meeting may be conducted in closed session. This meeting will be held remotely, please register online. Information about providing public comments can be found at the Board Meetings page as well as more information about the upcoming and previous board meetings, presentation materials and the PDAB's work. 

Also in Maryland, the Board of Pharmacy scheduled regular meetings throughout 2026, with sessions planned for April 15, May 20, June 17, July 15, August 19, September 16, October 21, November 18 and December 16. All meetings are scheduled for 9:30 am in Room 109/110 at 4201 Patterson Avenue in Baltimore.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-03-27T09:36:13-04:00March 27, 2026|Maryland|

Massachusetts

The Division of Insurance published final regulations related to the Licensing and Regulation of Pharmacy Benefit Managers – 211 CMR 157. The Division accepted the NACDS and Massachusetts Chain Pharmacy Council’s proposed amendment to require PBMs to disclose any common ownership interest with an insurance carrier. The release of the final regulation, which is effective March 13, aligns with ongoing work in the Massachusetts Legislature to consider additional PBM reform initiatives. 

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2026-03-27T09:35:32-04:00March 27, 2026|Massachusetts|
Go to Top